Screening Strategies for the Detection of Chlamydia Trachomatis and/or Neisseria Gonorrhoeae during Pregnancy: Clinical Utility, Safety, and Cost-Effectiveness

Details

Files
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1120-000

Question

  1. What is the clinical utility of different screening strategies for the detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) during pregnancy?
  2. What is the clinical evidence for the safety of different screening strategies for the detection of CT and/or GC during pregnancy?
  3. What is the cost-effectiveness of different screening strategies for the detection of CT and/or GC during pregnancy?

Key Message

Three non-randomized studies were identified regarding the clinical utility of different screening strategies for the detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae during pregnancy. No relevant studies were identified regarding the clinical evidence for the safety of different screening strategies for the detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae during pregnancy. Additionally, no economic evaluations were identified regarding the cost-effectiveness of different screening strategies for the detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae during pregnancy.